Michael F. Huang - 17 Jul 2024 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Sr. VP of Clinical Development
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol
SLNO
Transactions as of
17 Jul 2024
Transactions value $
$0
Form type
4
Filing time
19 Jul 2024, 09:03:42 UTC
Previous filing
30 Apr 2024
Next filing
23 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Award $0 +35K $0.00 35K 17 Jul 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. 50% of the RSUs subject to the award shall vest on the NDA Approval Date and 50% of the RSUs subject to the award shall vest on the one year anniversary of the NDA Approval Date, subject to the Reporting Person continuing as a service provider through each such date.
F2 Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.